Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Psilocybin Plus Psychotherapy Offers Lasting Benefit in Cancer, Depression

For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief for depressio

COVID Vaccine Protects Against Kidney Damage During Infection

MONDAY, June 16, 2025 Kidney damage is common during a severe case of COVID-19, but vaccination appears to protect people against this life-threatening side eff

Rheumatoid Arthritis On The Rise Worldwide, AI-Powered Study Estimates

MONDAY, June 16, 2025 Rheumatoid arthritis (RA) has steadily increased around the world during the past three decades, a new AI-powered study reports.The autoim

Bugaboo Recalls 18,000+ Giraffe High Chairs Due to Fall Risk

MONDAY, June 16, 2025 Parents, take note Bugaboo is recalling more than 18,000 of its Giraffe high chairs following reports of the legs separating from the fram

New COVID Variant, NB.1.8.1, May Now Make Up 1 in 3 U.S. Cases

MONDAY, June 16, 2025 A new COVID-19 variant that led to a spike in hospital cases across parts of Asia may now account for more than one-third of all COVID cas

Eating More Fruits and Veggies May Help You Sleep Better, Study Finds

SUNDAY, June 15, 2025 Struggling to get a good night s sleep A new study suggests that a natural solution might be found right in your fridge fruits and veggies

Building Strength May Take Less Exercise Than You Think

SATURDAY, June 14, 2025 Think you need to spend hours lifting weights to build muscle or get stronger Researchers at Florida Atlantic University say just a few

Novo Nordisk to Advance Subcutaneous and Oral Amycretin for Weight Management Into Phase 3 Clinical Development

Bagsv rd, Denmark, 12 June 2025 Novo Nordisk today announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight management

New Results for Johnson & Johnson’s Bleximenib Demonstrate Promising Antileukemic Activity in Combination with Venetoclax and Azacitidine for Acute Myeloid Leukemia

MILAN (June 12, 2025) Johnson Johnson (NYSE JNJ) today announced new Phase 1b data showing encouraging antileukemic activity and a promising safety profile for

Merck Initiates Phase 3 Study Evaluating V181 Dengue Vaccine Candidate

Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 Phase 3 clinical trial evaluating the s

Popular Keywords